(metastatic tumor cohort)
This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.
Testing the association between copy number variation 73 arm-level results and 7 clinical features across 158 patients, 2 significant findings detected with Q value < 0.25.
-
18p gain cnv correlated to 'NEOPLASM.DISEASESTAGE'.
-
18q gain cnv correlated to 'NEOPLASM.DISEASESTAGE'.
Table 1. Get Full Table Overview of the association between significant copy number variation of 73 arm-level results and 7 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 2 significant findings detected.
Clinical Features |
Time to Death |
AGE | GENDER |
DISTANT METASTASIS |
LYMPH NODE METASTASIS |
TUMOR STAGECODE |
NEOPLASM DISEASESTAGE |
||
nCNV (%) | nWild-Type | logrank test | t-test | Fisher's exact test | Chi-square test | Chi-square test | t-test | Chi-square test | |
18p gain | 19 (12%) | 139 |
0.873 (1.00) |
0.18 (1.00) |
0.219 (1.00) |
0.493 (1.00) |
0.273 (1.00) |
1.33e-05 (0.00577) |
|
18q gain | 11 (7%) | 147 |
0.863 (1.00) |
0.496 (1.00) |
0.343 (1.00) |
0.973 (1.00) |
0.403 (1.00) |
1.12e-06 (0.000489) |
|
1p gain | 22 (14%) | 136 |
0.152 (1.00) |
0.143 (1.00) |
0.639 (1.00) |
0.863 (1.00) |
0.43 (1.00) |
0.055 (1.00) |
|
1q gain | 54 (34%) | 104 |
0.329 (1.00) |
0.724 (1.00) |
0.733 (1.00) |
0.734 (1.00) |
0.146 (1.00) |
0.299 (1.00) |
|
2p gain | 13 (8%) | 145 |
0.779 (1.00) |
0.157 (1.00) |
0.251 (1.00) |
0.953 (1.00) |
0.8 (1.00) |
0.779 (1.00) |
|
2q gain | 11 (7%) | 147 |
0.613 (1.00) |
0.466 (1.00) |
0.529 (1.00) |
0.967 (1.00) |
0.809 (1.00) |
0.673 (1.00) |
|
3p gain | 16 (10%) | 142 |
0.955 (1.00) |
0.443 (1.00) |
0.421 (1.00) |
0.928 (1.00) |
0.325 (1.00) |
0.747 (1.00) |
|
3q gain | 21 (13%) | 137 |
0.64 (1.00) |
0.275 (1.00) |
0.474 (1.00) |
0.875 (1.00) |
0.278 (1.00) |
0.805 (1.00) |
|
4p gain | 16 (10%) | 142 |
0.369 (1.00) |
0.091 (1.00) |
0.789 (1.00) |
0.937 (1.00) |
0.254 (1.00) |
0.0565 (1.00) |
|
4q gain | 12 (8%) | 146 |
0.389 (1.00) |
0.0928 (1.00) |
0.766 (1.00) |
0.973 (1.00) |
0.477 (1.00) |
0.0471 (1.00) |
|
5p gain | 17 (11%) | 141 |
0.0307 (1.00) |
0.445 (1.00) |
0.6 (1.00) |
0.0224 (1.00) |
0.656 (1.00) |
0.659 (1.00) |
|
5q gain | 6 (4%) | 152 |
0.354 (1.00) |
0.227 (1.00) |
1 (1.00) |
0.992 (1.00) |
0.347 (1.00) |
0.53 (1.00) |
|
6p gain | 55 (35%) | 103 |
0.648 (1.00) |
0.513 (1.00) |
0.171 (1.00) |
0.735 (1.00) |
0.416 (1.00) |
0.43 (1.00) |
|
6q gain | 12 (8%) | 146 |
0.716 (1.00) |
0.8 (1.00) |
0.541 (1.00) |
0.249 (1.00) |
0.922 (1.00) |
0.44 (1.00) |
|
7p gain | 68 (43%) | 90 |
0.558 (1.00) |
0.843 (1.00) |
0.414 (1.00) |
0.0582 (1.00) |
0.225 (1.00) |
0.0522 (1.00) |
|
7q gain | 68 (43%) | 90 |
0.913 (1.00) |
0.285 (1.00) |
0.87 (1.00) |
0.0694 (1.00) |
0.254 (1.00) |
0.0138 (1.00) |
|
8p gain | 32 (20%) | 126 |
0.71 (1.00) |
0.404 (1.00) |
0.32 (1.00) |
0.0534 (1.00) |
0.684 (1.00) |
0.179 (1.00) |
|
8q gain | 48 (30%) | 110 |
0.962 (1.00) |
0.109 (1.00) |
0.377 (1.00) |
0.181 (1.00) |
0.614 (1.00) |
0.534 (1.00) |
|
11p gain | 9 (6%) | 149 |
0.979 (1.00) |
0.754 (1.00) |
0.484 (1.00) |
0.979 (1.00) |
0.0485 (1.00) |
0.695 (1.00) |
|
11q gain | 6 (4%) | 152 |
0.253 (1.00) |
0.878 (1.00) |
0.405 (1.00) |
0.992 (1.00) |
0.833 (1.00) |
0.533 (1.00) |
|
12p gain | 15 (9%) | 143 |
0.647 (1.00) |
0.098 (1.00) |
0.407 (1.00) |
0.105 (1.00) |
0.606 (1.00) |
0.239 (1.00) |
|
12q gain | 5 (3%) | 153 |
0.957 (1.00) |
0.557 (1.00) |
0.649 (1.00) |
0.995 (1.00) |
0.0166 (1.00) |
0.0181 (1.00) |
|
13q gain | 27 (17%) | 131 |
0.35 (1.00) |
0.373 (1.00) |
0.525 (1.00) |
0.605 (1.00) |
0.102 (1.00) |
0.084 (1.00) |
|
14q gain | 13 (8%) | 145 |
0.725 (1.00) |
0.983 (1.00) |
0.57 (1.00) |
0.96 (1.00) |
0.819 (1.00) |
0.885 (1.00) |
|
15q gain | 20 (13%) | 138 |
0.778 (1.00) |
0.788 (1.00) |
1 (1.00) |
0.898 (1.00) |
0.811 (1.00) |
0.805 (1.00) |
|
16p gain | 11 (7%) | 147 |
0.995 (1.00) |
0.665 (1.00) |
1 (1.00) |
0.96 (1.00) |
0.899 (1.00) |
0.558 (1.00) |
|
16q gain | 10 (6%) | 148 |
0.819 (1.00) |
0.993 (1.00) |
0.741 (1.00) |
0.967 (1.00) |
0.857 (1.00) |
0.84 (1.00) |
|
17p gain | 12 (8%) | 146 |
0.362 (1.00) |
0.584 (1.00) |
1 (1.00) |
0.199 (1.00) |
0.788 (1.00) |
0.0391 (1.00) |
|
17q gain | 20 (13%) | 138 |
0.505 (1.00) |
0.137 (1.00) |
0.628 (1.00) |
0.521 (1.00) |
0.352 (1.00) |
0.108 (1.00) |
|
19p gain | 10 (6%) | 148 |
0.149 (1.00) |
0.303 (1.00) |
0.516 (1.00) |
0.979 (1.00) |
0.985 (1.00) |
0.752 (1.00) |
|
19q gain | 12 (8%) | 146 |
0.462 (1.00) |
0.329 (1.00) |
0.219 (1.00) |
0.967 (1.00) |
0.551 (1.00) |
0.535 (1.00) |
|
20p gain | 48 (30%) | 110 |
0.854 (1.00) |
0.844 (1.00) |
0.596 (1.00) |
0.181 (1.00) |
0.753 (1.00) |
0.681 (1.00) |
|
20q gain | 59 (37%) | 99 |
0.434 (1.00) |
0.592 (1.00) |
0.316 (1.00) |
0.0419 (1.00) |
0.948 (1.00) |
0.639 (1.00) |
|
21q gain | 21 (13%) | 137 |
0.548 (1.00) |
0.932 (1.00) |
0.474 (1.00) |
0.276 (1.00) |
0.236 (1.00) |
0.0419 (1.00) |
|
22q gain | 43 (27%) | 115 |
0.207 (1.00) |
0.921 (1.00) |
0.468 (1.00) |
0.352 (1.00) |
0.112 (1.00) |
0.0413 (1.00) |
|
Xq gain | 3 (2%) | 155 |
0.62 (1.00) |
0.0699 (1.00) |
0.28 (1.00) |
||||
1p loss | 12 (8%) | 146 |
0.107 (1.00) |
0.919 (1.00) |
1 (1.00) |
0.973 (1.00) |
0.237 (1.00) |
0.23 (1.00) |
|
1q loss | 6 (4%) | 152 |
0.961 (1.00) |
0.464 (1.00) |
0.68 (1.00) |
0.988 (1.00) |
0.511 (1.00) |
0.84 (1.00) |
|
2p loss | 14 (9%) | 144 |
0.0944 (1.00) |
0.874 (1.00) |
1 (1.00) |
0.96 (1.00) |
0.909 (1.00) |
0.253 (1.00) |
|
2q loss | 13 (8%) | 145 |
0.154 (1.00) |
0.482 (1.00) |
0.768 (1.00) |
0.0149 (1.00) |
0.923 (1.00) |
0.132 (1.00) |
|
3p loss | 11 (7%) | 147 |
0.446 (1.00) |
0.412 (1.00) |
0.753 (1.00) |
0.979 (1.00) |
0.0756 (1.00) |
0.517 (1.00) |
|
3q loss | 11 (7%) | 147 |
0.519 (1.00) |
0.408 (1.00) |
0.343 (1.00) |
0.973 (1.00) |
0.149 (1.00) |
0.369 (1.00) |
|
4p loss | 16 (10%) | 142 |
0.723 (1.00) |
0.209 (1.00) |
0.0588 (1.00) |
0.0333 (1.00) |
0.774 (1.00) |
0.509 (1.00) |
|
4q loss | 16 (10%) | 142 |
0.706 (1.00) |
0.494 (1.00) |
0.0588 (1.00) |
0.0333 (1.00) |
0.78 (1.00) |
0.527 (1.00) |
|
5p loss | 22 (14%) | 136 |
0.906 (1.00) |
0.717 (1.00) |
0.818 (1.00) |
0.898 (1.00) |
0.861 (1.00) |
0.948 (1.00) |
|
5q loss | 33 (21%) | 125 |
0.919 (1.00) |
0.76 (1.00) |
0.548 (1.00) |
0.55 (1.00) |
0.596 (1.00) |
0.962 (1.00) |
|
6p loss | 14 (9%) | 144 |
0.888 (1.00) |
0.939 (1.00) |
0.781 (1.00) |
0.945 (1.00) |
0.868 (1.00) |
0.288 (1.00) |
|
6q loss | 64 (41%) | 94 |
0.541 (1.00) |
0.178 (1.00) |
0.868 (1.00) |
0.353 (1.00) |
0.397 (1.00) |
0.446 (1.00) |
|
8p loss | 21 (13%) | 137 |
0.541 (1.00) |
0.696 (1.00) |
0.636 (1.00) |
0.0873 (1.00) |
0.499 (1.00) |
0.298 (1.00) |
|
8q loss | 3 (2%) | 155 |
0.263 (1.00) |
0.63 (1.00) |
0.0586 (1.00) |
0.997 (1.00) |
0.453 (1.00) |
0.489 (1.00) |
|
9p loss | 91 (58%) | 67 |
0.381 (1.00) |
0.293 (1.00) |
0.742 (1.00) |
0.673 (1.00) |
0.0234 (1.00) |
0.0629 (1.00) |
|
9q loss | 72 (46%) | 86 |
0.917 (1.00) |
0.045 (1.00) |
0.0337 (1.00) |
0.424 (1.00) |
0.466 (1.00) |
0.0397 (1.00) |
|
10p loss | 69 (44%) | 89 |
0.209 (1.00) |
0.284 (1.00) |
0.139 (1.00) |
0.294 (1.00) |
0.17 (1.00) |
0.957 (1.00) |
|
10q loss | 76 (48%) | 82 |
0.66 (1.00) |
0.00546 (1.00) |
0.194 (1.00) |
0.268 (1.00) |
0.239 (1.00) |
0.928 (1.00) |
|
11p loss | 41 (26%) | 117 |
0.0858 (1.00) |
0.58 (1.00) |
0.0938 (1.00) |
0.0934 (1.00) |
0.0935 (1.00) |
0.0113 (1.00) |
|
11q loss | 44 (28%) | 114 |
0.0345 (1.00) |
0.636 (1.00) |
0.103 (1.00) |
0.134 (1.00) |
0.089 (1.00) |
0.00422 (1.00) |
|
12p loss | 9 (6%) | 149 |
0.618 (1.00) |
0.982 (1.00) |
0.316 (1.00) |
0.103 (1.00) |
0.161 (1.00) |
0.831 (1.00) |
|
12q loss | 17 (11%) | 141 |
0.838 (1.00) |
0.863 (1.00) |
0.293 (1.00) |
0.136 (1.00) |
0.523 (1.00) |
0.649 (1.00) |
|
13q loss | 25 (16%) | 133 |
0.962 (1.00) |
0.465 (1.00) |
0.658 (1.00) |
0.0919 (1.00) |
0.125 (1.00) |
0.617 (1.00) |
|
14q loss | 39 (25%) | 119 |
0.58 (1.00) |
0.32 (1.00) |
0.452 (1.00) |
0.11 (1.00) |
0.465 (1.00) |
0.259 (1.00) |
|
15q loss | 11 (7%) | 147 |
0.795 (1.00) |
0.287 (1.00) |
0.753 (1.00) |
0.00874 (1.00) |
0.344 (1.00) |
0.815 (1.00) |
|
16p loss | 12 (8%) | 146 |
0.316 (1.00) |
0.546 (1.00) |
0.219 (1.00) |
0.973 (1.00) |
0.896 (1.00) |
0.179 (1.00) |
|
16q loss | 28 (18%) | 130 |
0.00482 (1.00) |
0.854 (1.00) |
0.402 (1.00) |
0.122 (1.00) |
0.683 (1.00) |
0.173 (1.00) |
|
17p loss | 37 (23%) | 121 |
0.277 (1.00) |
0.421 (1.00) |
0.701 (1.00) |
0.276 (1.00) |
0.708 (1.00) |
0.62 (1.00) |
|
17q loss | 16 (10%) | 142 |
0.094 (1.00) |
0.983 (1.00) |
1 (1.00) |
0.105 (1.00) |
0.145 (1.00) |
0.409 (1.00) |
|
18p loss | 32 (20%) | 126 |
0.465 (1.00) |
0.489 (1.00) |
0.843 (1.00) |
0.768 (1.00) |
0.0799 (1.00) |
0.228 (1.00) |
|
18q loss | 28 (18%) | 130 |
0.275 (1.00) |
0.658 (1.00) |
1 (1.00) |
0.204 (1.00) |
0.484 (1.00) |
0.271 (1.00) |
|
19p loss | 13 (8%) | 145 |
0.711 (1.00) |
0.446 (1.00) |
0.0346 (1.00) |
0.0034 (1.00) |
0.621 (1.00) |
0.381 (1.00) |
|
19q loss | 15 (9%) | 143 |
0.786 (1.00) |
0.914 (1.00) |
0.0997 (1.00) |
0.0034 (1.00) |
0.518 (1.00) |
0.659 (1.00) |
|
20p loss | 6 (4%) | 152 |
0.311 (1.00) |
0.282 (1.00) |
0.405 (1.00) |
0.0316 (1.00) |
0.974 (1.00) |
0.573 (1.00) |
|
21q loss | 20 (13%) | 138 |
0.786 (1.00) |
0.94 (1.00) |
0.628 (1.00) |
0.887 (1.00) |
0.846 (1.00) |
0.133 (1.00) |
|
22q loss | 11 (7%) | 147 |
0.88 (1.00) |
0.692 (1.00) |
0.343 (1.00) |
0.96 (1.00) |
0.97 (1.00) |
0.37 (1.00) |
|
Xq loss | 6 (4%) | 152 |
0.702 (1.00) |
0.501 (1.00) |
0.0348 (1.00) |
0.995 (1.00) |
0.975 (1.00) |
0.846 (1.00) |
P value = 1.33e-05 (Chi-square test), Q value = 0.0058
Table S1. Gene #28: '18p gain mutation analysis' versus Clinical Feature #7: 'NEOPLASM.DISEASESTAGE'
nPatients | STAGE I | STAGE IA | STAGE IB | STAGE II | STAGE IIA | STAGE IIB | STAGE IIC | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IIIC | STAGE IV |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 17 | 9 | 13 | 18 | 8 | 9 | 8 | 7 | 6 | 17 | 18 | 5 |
18P GAIN MUTATED | 3 | 0 | 0 | 2 | 0 | 0 | 6 | 0 | 3 | 1 | 3 | 0 |
18P GAIN WILD-TYPE | 14 | 9 | 13 | 16 | 8 | 9 | 2 | 7 | 3 | 16 | 15 | 5 |
Figure S1. Get High-res Image Gene #28: '18p gain mutation analysis' versus Clinical Feature #7: 'NEOPLASM.DISEASESTAGE'
![](D28V7.png)
P value = 1.12e-06 (Chi-square test), Q value = 0.00049
Table S2. Gene #29: '18q gain mutation analysis' versus Clinical Feature #7: 'NEOPLASM.DISEASESTAGE'
nPatients | STAGE I | STAGE IA | STAGE IB | STAGE II | STAGE IIA | STAGE IIB | STAGE IIC | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IIIC | STAGE IV |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 17 | 9 | 13 | 18 | 8 | 9 | 8 | 7 | 6 | 17 | 18 | 5 |
18Q GAIN MUTATED | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 2 | 0 | 2 | 0 |
18Q GAIN WILD-TYPE | 16 | 9 | 13 | 18 | 8 | 9 | 3 | 7 | 4 | 17 | 16 | 5 |
Figure S2. Get High-res Image Gene #29: '18q gain mutation analysis' versus Clinical Feature #7: 'NEOPLASM.DISEASESTAGE'
![](D29V7.png)
-
Mutation data file = broad_values_by_arm.mutsig.cluster.txt
-
Clinical data file = SKCM-TM.clin.merged.picked.txt
-
Number of patients = 158
-
Number of significantly arm-level cnvs = 73
-
Number of selected clinical features = 7
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.